Albert, a pioneering company in the realm of chemistry-native artificial intelligence, has successfully raised $55 million in a Series B funding round led by TCV. This substantial investment will be directed towards expanding Albert's AI capabilities, specifically within research and development sectors of the chemicals and materials industries. This funding round also saw participation from new investors such as Delta-v Capital, Socium Ventures, HighSage Ventures, Coral Capital, and Legion VC, along with the continued support of existing investors like Coatue, J.P. Morgan Growth Equity Partners, Index Ventures, and Applied Ventures.
What Happened
Albert's Oakland-based operations have developed Albert OS, an operating system tailored for chemistry and materials science R&D. The platform is renowned for integrating specialized AI with robust enterprise security and governance features, such as zero data retention, fine-grained access controls, and reasoning audit trails. Notably, Albert's chemistry-native model, Valence, has demonstrated remarkable accuracy, outperforming general-purpose AI models by 45 times in scientific query retrieval, as evidenced by their FormBench chemistry benchmark.
The platform is already employed by industry giants including AkzoNobel, Avient, BASF, Chemours, Clorox, Henkel, Kenvue, and Nouryon. Albert's Ask Albert product empowers scientists to engage with research data through natural language, facilitating the orchestration of tools, models, and agents. This application enhances the surfacing of institutional knowledge, formulation proposals, experimental design, and complex data analysis. The past year has seen substantial growth in Albert's adoption, with a 26-fold increase in project creation and a sixfold rise in the number of scientists utilizing Albert OS across 44 countries.
What This Means for Your Business
For businesses operating within the AECM and government contracting sectors, Albert's advancements present significant opportunities to streamline and accelerate R&D processes. The adoption of chemistry-native AI could lead to reduced product development cycles and enhanced competitive positioning by turning extensive lab data into actionable insights faster than traditional methods. This is particularly crucial for entities seeking to leverage federal funding opportunities for innovative research.
Albert's platform, with its enterprise security features and compliance with advanced governance protocols, aligns well with evolving regulatory requirements, including CMMC and NIST standards. Companies can benefit from the platform's ability to integrate with existing R&D workflows, potentially leading to substantial ROI by optimizing research operations and enhancing product development efficiency.
What US Operators Should Watch
US operators should closely monitor the evolution of chemistry-native AI and its integration into mainstream R&D processes. As Albert continues to expand its platform's capabilities, businesses should evaluate the potential for incorporating such technologies into their operations to maintain a competitive edge. Additionally, staying informed about future funding rounds or strategic partnerships involving Albert could present new opportunities for collaboration or investment.
Source: https://pulse2.com/albert-raises-55-million-series-b-led-by-tcv-to-scale-chemistry-native-ai-for-rd/
Is your firm ready for what’s next?
VisioneerIT helps AECM and government contractors modernize operations, achieve compliance, and implement AI.
Explore VisioneerIT Solutions →
